Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 01, 2024

SELL
$33.32 - $42.1 $13,328 - $16,840
-400 Reduced 2.23%
17,500 $646,000
Q2 2023

Aug 07, 2023

BUY
$30.28 - $38.74 $542,012 - $693,446
17,900 New
17,900 $645,000
Q4 2020

Feb 12, 2021

SELL
$25.81 - $43.62 $498,133 - $841,866
-19,300 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$25.74 - $29.63 $48,906 - $56,297
-1,900 Reduced 8.96%
19,300 $507,000
Q2 2020

Aug 13, 2020

BUY
$16.25 - $26.81 $344,500 - $568,372
21,200 New
21,200 $568,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.57B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.